Portasystemic Shunt, Transjugular Intrahepatic
"Portasystemic Shunt, Transjugular Intrahepatic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A type of surgical portasystemic shunt to reduce portal hypertension with associated complications of esophageal varices and ascites. It is performed percutaneously through the jugular vein and involves the creation of an intrahepatic shunt between the hepatic vein and portal vein. The channel is maintained by a metallic stent. The procedure can be performed in patients who have failed sclerotherapy and is an additional option to the surgical techniques of portocaval, mesocaval, and splenorenal shunts. It takes one to three hours to perform. (JAMA 1995;273(23):1824-30)
MeSH Number(s)
E04.035.760.795
E04.100.814.868.937.830
Concept/Terms
Portasystemic Shunt, Transjugular Intrahepatic- Portasystemic Shunt, Transjugular Intrahepatic
- TIPSS
- Shunt, Transjugular Intrahepatic Portosystemic
- Portosystemic Shunt, Transjugular Intrahepatic
- Shunt, Transjugular Intrahepatic Portasystemic
- Transjugular Intrahepatic Portasystemic Shunt
Below are MeSH descriptors whose meaning is more general than "Portasystemic Shunt, Transjugular Intrahepatic".
Below are MeSH descriptors whose meaning is more specific than "Portasystemic Shunt, Transjugular Intrahepatic".
This graph shows the total number of publications written about "Portasystemic Shunt, Transjugular Intrahepatic" by people in Harvard Catalyst Profiles by year, and whether "Portasystemic Shunt, Transjugular Intrahepatic" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 1997 | 1 | 0 | 1 |
| 1998 | 1 | 0 | 1 |
| 1999 | 1 | 0 | 1 |
| 2001 | 1 | 2 | 3 |
| 2002 | 3 | 0 | 3 |
| 2003 | 1 | 0 | 1 |
| 2004 | 2 | 0 | 2 |
| 2006 | 0 | 1 | 1 |
| 2008 | 2 | 0 | 2 |
| 2009 | 2 | 0 | 2 |
| 2010 | 2 | 0 | 2 |
| 2011 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
| 2014 | 2 | 0 | 2 |
| 2015 | 3 | 2 | 5 |
| 2016 | 5 | 0 | 5 |
| 2017 | 5 | 0 | 5 |
| 2018 | 3 | 1 | 4 |
| 2019 | 1 | 0 | 1 |
| 2020 | 4 | 0 | 4 |
| 2021 | 5 | 0 | 5 |
| 2022 | 4 | 0 | 4 |
| 2023 | 1 | 0 | 1 |
Below are the most recent publications written about "Portasystemic Shunt, Transjugular Intrahepatic" by people in Profiles.
-
Transjugular Intrahepatic Portosystemic Shunt and Thrombectomy (TIPS-Thrombectomy) for Symptomatic Acute Noncirrhotic Portal Vein Thrombosis. J Vasc Interv Radiol. 2023 08; 34(8):1373-1381.e3.
-
Technical Feasibility of Suction Thrombectomy Using a Large-Bore Aspiration System in the Portomesenteric Venous System. J Vasc Interv Radiol. 2023 03; 34(3):351-356.
-
Development of a Thalassemia International Prognostic Scoring System (TIPSS). Blood Cells Mol Dis. 2023 03; 99:102710.
-
Filter-Assisted Shunt Embolization of Large Portosystemic Shunts: Technical Feasibility, Safety, and Outcomes. Cardiovasc Intervent Radiol. 2022 Oct; 45(10):1540-1546.
-
Presentation, Management, and Outcome of Congenital Portosystemic Shunts in Children: The Boston Children's Hospital Experience. J Pediatr Gastroenterol Nutr. 2022 07 01; 75(1):81-87.
-
Accelerated balloon-retrograde transvenous obliteration (BRTO): an effective tool in the Arsenal against isolated gastric varices (IGV). BMJ Case Rep. 2021 Sep 06; 14(9).
-
Radiologically Placed Peritoneovenous Shunt is an Acceptable Treatment Alternative for Refractory Ascites Due to End-Stage Liver Disease. J Vasc Interv Radiol. 2021 11; 32(11):1606-1614.
-
Occult Hepatocellular Carcinoma Associated With Transjugular Intrahepatic Portosystemic Shunts in Liver Transplant Recipients. Liver Transpl. 2021 09; 27(9):1248-1261.
-
North American Practice-Based Recommendations for Transjugular Intrahepatic Portosystemic Shunts in Portal Hypertension. Clin Gastroenterol Hepatol. 2022 08; 20(8):1636-1662.e36.
-
TIPS for Adults Without Cirrhosis With Chronic Mesenteric Venous Thrombosis and EHPVO Refractory to Standard-of-Care Therapy. Hepatology. 2021 11; 74(5):2735-2744.